Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-08-08Clinical Trial Update: Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma [Phase 1, Phase 2]
An early-phase study of flavopiridol (alvocidib) in patients with relapsed or refractory lymphoma or multiple myeloma; the Phase 1/2 trial w…
-
CLINICAL_TRIALS trial_result · 2016-08-04Clinical Trial Update: Sitagliptin Umbilical Cord Blood Transplant Study [Phase 2]
Phase 2 clinical trial update on sitagliptin in the setting of umbilical cord blood transplantation, with results posted in 2016 for several…
-
CLINICAL_TRIALS withdrawal · 2016-07-26Clinical Trial Update: A Study of Duvelisib and Venetoclax in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Indolent or Aggressive Non-Hodgkin Lymphoma, Who Have Not Previously Received a Bcl-2 or PI3K Inhibitor [Phase 1]
A Phase 1 study of the combination of duvelisib and venetoclax in relapsed or refractory chronic lymphocytic leukemia, small lymphocytic lym…
-
CLINICAL_TRIALS trial_result · 2016-07-25Clinical Trial Update: Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus [Phase 2]
Phase 2 study evaluating unrelated cord blood transplantation using tacrolimus and sirolimus for hematologic malignancies has completed.
-
CLINICAL_TRIALS research · 2016-07-20Clinical Trial Update: Observational Study in Participants With Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL) in Latin America
This is a completed observational study conducted in Latin America evaluating participants with chronic lymphocytic leukemia, multiple myelo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-07-19Clinical Trial Update: Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating combination chemotherapy and monoclonal antibody therapy in Non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS research · 2016-07-19Clinical Trial Update: BEB Conditioning Regimen for Autologous Stem-cell Transplantation(ASCT) in Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating a BEB conditioning regimen for autologous stem-cell transplantation in non-Hodgkin lymphoma, with the cu…
-
CLINICAL_TRIALS trial_result · 2016-07-18Clinical Trial Update: Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders [Phase 2]
A Phase 2 trial testing nonmyeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors for multiple hematologic dis…
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating a combination chemotherapy regimen for relapsed or refractory intermediate- or high-grade Non-Hodgkin ly…
-
CLINICAL_TRIALS withdrawal · 2016-07-14Clinical Trial Update: Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies [Phase 2]
A Phase 2 clinical trial evaluating single or double donor umbilical cord blood transplant for high-risk hematologic malignancies has been w…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Previously Untreated Aggressive Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial comparing two combination chemotherapy regimens in previously untreated patients with aggressive Non-Hodgkin lymphoma (stages …
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Rituximab in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease [Phase 2]
Phase 2 trial update on Rituximab for Non-Hodgkin's lymphoma or Hodgkin's disease; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: A Phase Ib Study of the Safety, Tolerability and Efficacy of LY2780301 in Combination With Gemcitabine [Phase 1]
Phase Ib trial assessing safety, tolerability, and preliminary efficacy of LY2780301 in combination with gemcitabine in solid tumors and non…
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: Study of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic Malignancies [Phase 1]
Phase 1 study of idelalisib (IPI-145) in combination with Rituximab or Bendamustine/Rituximab in hematologic malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 trial evaluating the combination of Yttrium-90 ibritumomab tiuxetan and rituximab in patients with Non-Hodgkin lymphoma has comple…
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Rituximab and Galiximab in Treating Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating rituximab in combination with galiximab for non-Hodgkin lymphoma has completed, with results not detailed in the pr…
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma
A diagnostic study in patients with aggressive non-Hodgkin's lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-04Clinical Trial Update: Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia [Phase 2]
A Phase 2 trial of a combination chemotherapy regimen for non-Hodgkin lymphoma and acute lymphoblastic leukemia has completed.
-
CLINICAL_TRIALS research · 2016-07-01Clinical Trial Update: Observational Study of Diffuse Large B Cell Primary Breast Lymphomas Treated With RCHOP +/- XRT
This entry notes a terminated observational study at Stanford evaluating the RCHOP chemotherapy regimen with or without radiation therapy fo…
-
CLINICAL_TRIALS trial_result · 2016-06-28Clinical Trial Update: Etoposide in Treating Patients With Relapsed Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 study evaluating the efficacy and safety of etoposide in patients with relapsed non-Hodgkin lymphoma has completed.
-
FDA approval · 2016-06-23FDA Approved: BENDEKA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Bendeka (bendamustine hydrochloride) submitted by Teva Pharmaceuticals USA, Inc., indicating reg…
-
CLINICAL_TRIALS trial_result · 2016-06-22Clinical Trial Update: Pilot Study of Autologous T Lymphocytes With ADCC in Patients With CD20-Positive B-Cell Malignancies [Phase 1, Phase 2]
Phase 1/Phase 2 pilot study evaluating autologous T lymphocytes with antibody-dependent cellular cytotoxicity in CD20-positive B-cell malign…
-
CLINICAL_TRIALS trial_result · 2016-06-10Clinical Trial Update: Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors [EARLY_Phase 1]
Early-phase 1 clinical trial update for nelfinavir in gammaherpesvirus-related tumors, noting termination of the study despite investigation…
-
CLINICAL_TRIALS research · 2016-06-06Clinical Trial Update: Identification of Hematological Malignancies and Therapy Predication Using microRNAs as a Diagnostic Tool
Clinical trial update describes research on using microRNAs as a diagnostic tool to identify hematological malignancies and predict therapeu…
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: VEGF Trap in Treating Patients With Relapsed or Refractory Solid Tumors or Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial update of aflibercept (VEGF Trap) in patients with relapsed or refractory solid tumors or Non-Hodgkin's lymphoma; the study ha…